Evidence map›Paper›PMID 32404074›Full record

ArticleBMC cancer2020

Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture.

L Ehlen, J Arndt, D Treue, P Bischoff, F N Loch, E M Hahn, K Kotsch, F Klauschen, K Beyer, G A Margonis and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Molecular alterations in pancreatic tumors.World journal of gastroenterology · 2021
    Review
  9. Review
  10. From Donor to the Lab: A Fascinating Journey of Primary Cell Lines.Frontiers in cell and developmental biology · 2021
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

L EhlenDepartment of General, Visceral and Vascular Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany. lukas.ehlen@charite.de.ORCID http://orcid.org/0000-0002-0820-6594
J ArndtDepartment of General, Visceral and Vascular Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
D TreueInstitute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
P BischoffInstitute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
F N LochDepartment of General, Visceral and Vascular Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
E M HahnDepartment of General, Visceral and Vascular Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
K KotschDepartment of General, Visceral and Vascular Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
F KlauschenInstitute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
K BeyerDepartment of General, Visceral and Vascular Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
G A MargonisDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, USA.
M E KreisDepartment of General, Visceral and Vascular Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
C KamphuesDepartment of General, Visceral and Vascular Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEJohns Hopkins University · US

Funding

Berliner Krebsgesellschaft EHFF201726
6 · The paper itself

Abstract

backgroundPancreatic cancer remains a fatal disease. Experimental systems are needed for personalized treatment strategies, drug testing and to further understand tumor biology. Cell cultures can serve as an excellent preclinical platform, but their generation remains challenging.

methodsTumor cells from surgically removed pancreatic ductal adenocarcinoma (PDAC) specimens were cultured under novel protocols. Cellular growth and composition were analyzed and culture conditions were continuously optimized. Characterization of cell cultures and primary tumors was performed via hematoxylin and eosin (HE) and immunofluorescence (IF) staining.

resultsProtocols for two- and three-dimensional PDAC primary cell cultures could successfully be established. Primary cell culture depended on dissociation techniques, growth factor supplementation and extracellular matrix components containing Matrigel being crucial for the transformation to three-dimensional PDAC organoids. The generated cultures showed to be highly resemblant to established PDAC primary cell cultures. HE and IF staining for cell culture and corresponding primary tumor characterization could successfully be performed.

conclusionsThe work presented herein shows novel and effective methods to successfully establish primary PDAC cell cultures in a distinct time frame. Factors contributing to cell growth and differentiation could be identified with important implications for further primary cell culture protocols. The established protocols might serve as novel tools in personalized tumor therapy.

Indexed as

Models, BiologicalCarcinoma, Pancreatic DuctalHumansIn Vitro TechniquesOrganoidsPancreatic NeoplasmsPrimary Cell CultureTumor Cells, CulturedOrganoidsPDACPrimary cell culture

Identifiers

PMID32404074
PMCPMC7222463
OpenAlexW3026717936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.